Skip to main content
Caplight Logo









eversyn GmbH

eversyn GmbH

Private
MagdeburgHealthcare & Life Scienceshttps://www.eversyn.de/

Last Round

Grant

Jun 1, 2026

Total Funding Raised

$2.81M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

eversyn GmbH is a biotechnology company that develops cell-free enzymatic platforms for the cost-effective production of complex glycans, including human milk oligosaccharides and nucleotide sugars for nutrition and pharmaceutical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

cell-free biosynthesishuman milk oligosaccharidesHMOnucleotide sugarsglycoengineeringbiocatalysisglycosyltransferasesglycosidasescustom synthesisbiotech reagentssynthetic biologyenzyme productionprotein glycosylationbiotech manufacturingsynbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

eversyn GmbH Comparables

Compare eversyn GmbH with similar companies based on industry and business-model similarity.

eversyn GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inbiose
78%
CD BioGlyco
78%
Zymtronix
78%

eversyn GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 1, 2026
SeedMar 20, 2025
GrantOct 20, 2022

Key People

Founding team and executive leadership

Rachel Thu Nguyen

Co-Founder & Chief Business Officer

Founding Team

Volker Landschütze

Chief Technology Officer - CTO (fractional)

Executive Team

Ursula La Cognata

Chief Operating Officer COO fractional

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 10, 2026

    Grew 38% QoQ, from 8 to 11 employees.

  • Jun 1, 2026

    Received grant funding to support operations.

eversyn GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

eversyn GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about eversyn GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersMagdeburg
Employee Range14
Year Founded2022
Last FundingJun 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?